Status:
COMPLETED
Non-invasive Substrate Evaluation in Atrial Fibrillation
Lead Sponsor:
Hospital Clinic of Barcelona
Collaborating Sponsors:
Gregorio Marañón Hospital
Conditions:
C14.280.067.198
Eligibility:
All Genders
18-80 years
Brief Summary
The study aims to assess the right and left atrial electrophysiological substrate in atrial fibrillation patients using the invasive electroanatomic map (basal and with extraestimulus) as well as its ...
Eligibility Criteria
Inclusion
- Atrial fibrillation paroxysmal or persistent with criteria for percutaneous ablation
Exclusion
- Cardiomiopathy (FEVI\<40%) or significant valvulopathy.
- MRI not possible or contraindicated.
- Previous atrial fibrillation ablation.
Key Trial Info
Start Date :
February 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2022
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04496336
Start Date
February 20 2020
End Date
November 20 2022
Last Update
March 6 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Gregorio Marañon
Madrid, Barcelona, Spain
2
Hospital Clinic de Barcelona
Barcelona, Spain, 08036